Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts
Shijun Zhu(Soochow University), Mamoru Shoji(Emory University), Terry W. Moore(University of Illinois Chicago), Fadlo R. Khuri(American University of Beirut Medical Center), Nao Morii(Emory University), Richard F. Arrendale(Emory University), Haian Fu(Emory University), Hongzheng Zhang(Zhujiang Hospital), Taylor J. Evers(Kennesaw State University), Zhuo Chen(East China University of Science and Technology), Aiming Sun(Emory University), Dong Shin(Emory University), James P. Snyder(Emory University), Gabriel Sica(Emory University), Prabhakar Reddy(Emory University), Randy B. Howard(Emory University)
Cited by 14
Related Papers
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
|The Lancet Oncology|2013|748
B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity
|Immunity|2003|702